Cargando…
Identification of promising nutraceuticals against filarial immune-modulatory proteins: insights from in silico and ex vivo studies
Lymphatic filariasis is a neglected tropical disease affecting over 863 million people in 47 countries of the world. The anti-filarial drugs, diethylcarbamazine, albendazole, and ivermectin, are effective only at the larval stages and have proven completely ineffective as adulticides. Besides this,...
Autores principales: | Kumar, Vipin, Mishra, Ayushi, Singh, Anchal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366595/ https://www.ncbi.nlm.nih.gov/pubmed/36105981 http://dx.doi.org/10.1039/d2ra03287b |
Ejemplares similares
-
Lymphatic filarial serum proteome profiling for identification and characterization of diagnostic biomarkers
por: Kumar, Vipin, et al.
Publicado: (2022) -
Deciphering the anti-filarial potential of bioactive compounds from Ocimum sanctum: a combined experimental and computational study
por: Mishra, Ayushi, et al.
Publicado: (2022) -
S-(−)-Oleocanthal Ex Vivo Modulatory Effects on Gut Microbiota
por: Qusa, Mohammed H., et al.
Publicado: (2023) -
In Vitro, In Silico and In Vivo Studies of Ursolic Acid as an Anti-Filarial Agent
por: Kalani, Komal, et al.
Publicado: (2014) -
Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies
por: Waclawiková, Barbora, et al.
Publicado: (2022)